Noelle Loconte, MD
Medical Oncology · Madison, WINPI 1972568269
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,575 of the $4,075 with a category attached, or 87.7%. AbbVie accounts for 87.7% of it on its own, with 1 other manufacturer making up the rest.
Across 2 payments — averaging $2037.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Personal Genome Diagnostics Inc$500
Across 28 payments — averaging $5520.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Exact Sciences$57K
- Bristol Myers Squibb$43K
- Merck$30K
- Taiho Oncology, Inc.$25K
What the payments were for
- Consulting fees$3,57588%
- Speaking & faculty fees$50012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 1 | $3,575 |
| Personal Genome Diagnostics Inc | 1 | $500 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Creon$3,575
- PGDx elio tissue complete$500
How this compares
$4,075 in reported general payments places this provider in the 70th percentile of 54 medical oncology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 29 | $23,718 |
| Oxycodone Hcl | 21 | $453 |
| Dexamethasone | 31 | $368 |
| Ondansetron Hcl | 38 | $337 |
| Prochlorperazine Maleate | 12 | $193 |
| Duloxetine Hcl | 24 | $169 |
| Pantoprazole Sodium | 13 | $159 |
| Amlodipine Besylate | 23 | $66 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Madison
- Joshua LangMadison$114K
- Dustin DemingMadison$100K
- Kari WisinskiMadison$43K
- Justine BruceMadison$25K
- Glenn LiuMadison$13K
- Toby CampbellMadison$12K
- Douglas McNeelMadison$7K
- Anthony SerritellaMadison$2K
- Howard BaileyMadison$553
- George WildingMadison$383
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.